RGS3 and astrocytoma (excluding glioblastoma): The order of potency of adenosine agonists in the down-regulation of RGS3 expression in astrocytoma cells is NECA>CPA/IB-MECA> CGS21680 indicating that the effect is due to activation of A2B-receptors (Fig 2C).